Indeed, a study by Ortiz et al. [72] showed that systemic administration of 5 × 105 BM-MSCs in mice with BLM-induced lung fibrosis protects the lungs from injury by reducing inflammation, collagen deposition, and MMP (MMP-2, -9, -13) activation in lung tissue. Here, MMP2 is linked to pulmonary fibrosis.